$35M Share Offering
New Cash in Hand, Threshold Plans Hypoxia Cancer Efforts
Threshold Pharmaceuticals Inc. plans to raise about $35 million through the sale of stock and warrants, money that will help advance its cancer drug pipeline and extend its cash well into 2011. (BioWorld Today)